Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial

BACKGROUND: Extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales are common causes of bloodstream infection. ESBL-producing bacteria are typically resistant to third-generation cephalosporins and result in a sizeable economic and public health burden. AmpC-producing Enterobact...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark D., Littleford, Roberta, Paterson, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060904/
https://www.ncbi.nlm.nih.gov/pubmed/33888139
http://dx.doi.org/10.1186/s13063-021-05206-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060904/
https://www.ncbi.nlm.nih.gov/pubmed/33888139
http://dx.doi.org/10.1186/s13063-021-05206-8

Ejemplares similares